{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:20:37Z","timestamp":1791285637077,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T00:00:00Z","timestamp":1709856000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.apsb.2024.03.011","type":"journal-article","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T01:22:35Z","timestamp":1710120155000},"page":"2613-2630","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Glucagon-like peptide-1 receptor agonists rescued diabetic vascular endothelial damage through suppression of aberrant STING signaling"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9231-4426","authenticated-orcid":false,"given":"Xuemin","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siying","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xixiang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheyao","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shasha","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3168-8034","authenticated-orcid":false,"given":"Ting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiping","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaotian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyi","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6552-9138","authenticated-orcid":false,"given":"Li","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heying","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5893-6114","authenticated-orcid":false,"given":"Yan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaochong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3098-6662","authenticated-orcid":false,"given":"Guojun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2024.03.011_bib1","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.ophtha.2021.04.027","article-title":"Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis","volume":"128","author":"Teo","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.apsb.2024.03.011_bib2","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1001\/jama.2017.7596","article-title":"Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013","volume":"317","author":"Wang","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.apsb.2024.03.011_bib3","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1001\/jamainternmed.2019.2396","article-title":"Evaluation of the cascade of diabetes care in the United States, 2005\u20132016","volume":"179","author":"Kazemian","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.apsb.2024.03.011_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/srep42201","article-title":"Detailed vascular anatomy of the human retina by projection-resolved optical coherence tomography angiography","volume":"7","author":"Campbell","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2024.03.011_bib5","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1074\/jbc.M209909200","article-title":"How does the eye breathe? Evidence for neuroglobin-mediated oxygen supply in the mammalian retina","volume":"278","author":"Schmidt","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2024.03.011_bib6","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93751","article-title":"Diabetic retinopathy: current understanding, mechanisms, and treatment strategies","volume":"2","author":"Duh","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.apsb.2024.03.011_bib7","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2024.03.011_bib8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2024.03.011_bib9","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz069","article-title":"Glucagon-like peptide 1 receptor agonists, diabetic retinopathy and angiogenesis: the AngioSafe type 2 diabetes study","volume":"105","author":"Gaborit","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.apsb.2024.03.011_bib10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2024.03.011_bib11","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.2337\/dc18-1893","article-title":"Assessing the association between GLP-1 receptor agonist use and diabetic retinopathy through the FDA adverse event reporting system","volume":"42","author":"Wang","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.apsb.2024.03.011_bib12","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.ajpath.2020.01.011","article-title":"The anti-inflammatory effects of glucagon-like peptide receptor agonist lixisenatide on the retinal nuclear and nerve fiber layers in an animal model of early type 2 diabetes","volume":"190","author":"Chung","year":"2020","journal-title":"Am J Pathol"},{"key":"10.1016\/j.apsb.2024.03.011_bib13","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2337\/db15-0443","article-title":"Topical administration of GLP-1 receptor agonists prevents retinal neurodegeneration in experimental diabetes","volume":"65","author":"Hernandez","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.apsb.2024.03.011_bib14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/aps.2011.149","article-title":"Glucagon-like peptide-1 activates endothelial nitric oxide synthase in human umbilical vein endothelial cells","volume":"33","author":"Ding","year":"2012","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.apsb.2024.03.011_bib15","doi-asserted-by":"crossref","first-page":"E355","DOI":"10.1152\/ajpendo.00283.2013","article-title":"GLP-1 increases microvascular recruitment but not glucose uptake in human and rat skeletal muscle","volume":"306","author":"Sjoberg","year":"2014","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.apsb.2024.03.011_bib16","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93382","article-title":"Myeloid cell modulation by a GLP-1 receptor agonist regulates retinal angiogenesis in ischemic retinopathy","volume":"6","author":"Zhou","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.apsb.2024.03.011_bib17","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/atv.0000615456.97862.30","article-title":"Endothelial GLP-1 (glucagon-like peptide-1) receptor mediates cardiovascular protection by liraglutide in mice with experimental arterial hypertension","volume":"40","author":"Helmstadter","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.apsb.2024.03.011_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106320","article-title":"The anti-inflammatory and immunological properties of GLP-1 receptor agonists","volume":"182","author":"Bendotti","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.apsb.2024.03.011_bib19","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/s41577-021-00524-z","article-title":"The cGAS\u2013STING pathway as a therapeutic target in inflammatory diseases","volume":"21","author":"Decout","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.apsb.2024.03.011_bib20","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJMoa1312625","article-title":"Activated STING in a vascular and pulmonary syndrome","volume":"371","author":"Liu","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2024.03.011_bib21","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1161\/ATVBAHA.117.309017","article-title":"STING\u2013IRF3 triggers endothelial inflammation in response to free fatty acid-induced mitochondrial damage in diet-induced obesity","volume":"37","author":"Mao","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.apsb.2024.03.011_bib22","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.apsb.2021.05.011","article-title":"The cGAS\u2013STING signaling in cardiovascular and metabolic diseases: future novel target option for pharmacotherapy","volume":"12","author":"Oduro","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.03.011_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2022.109213","article-title":"Hyperlipidemia induces proinflammatory responses by activating STING pathway through IRE1\u03b1\u2013XBP1 in retinal endothelial cells","volume":"112","author":"Wen","year":"2023","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.apsb.2024.03.011_bib24","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.168945","article-title":"Activated cGAS\/STING signaling elicits endothelial cell senescence in early diabetic retinopathy","volume":"8","author":"Liu","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.apsb.2024.03.011_bib25","doi-asserted-by":"crossref","first-page":"5075","DOI":"10.1021\/acs.jmedchem.5b00468","article-title":"Identification of a potent inhibitor of CREB-mediated gene transcription with efficacious in\u00a0vivo anticancer activity","volume":"58","author":"Xie","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2024.03.011_bib26","article-title":"The Tabula sapiens: a multiple-organ, single-cell transcriptomic atlas of humans","volume":"376","author":"Tabula Sapiens","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.apsb.2024.03.011_bib27","doi-asserted-by":"crossref","first-page":"762","DOI":"10.2337\/db21-0551","article-title":"Single-cell transcriptomics reveals novel role of microglia in fibrovascular membrane of proliferative diabetic retinopathy","volume":"71","author":"Hu","year":"2022","journal-title":"Diabetes"},{"key":"10.1016\/j.apsb.2024.03.011_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2021.01.011","article-title":"Pathological angiogenesis in retinopathy engages cellular senescence and is amenable to therapeutic elimination via BCL-xL inhibition","volume":"33","author":"Crespo-Garcia","year":"2021","journal-title":"Cell Metabol"},{"key":"10.1016\/j.apsb.2024.03.011_bib29","doi-asserted-by":"crossref","first-page":"5065","DOI":"10.1167\/iovs.17-22091","article-title":"Therapeutic effects of PPAR\u03b1 agonist on ocular neovascularization in models recapitulating neovascular age-related macular degeneration","volume":"58","author":"Qiu","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.apsb.2024.03.011_bib30","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1097\/IAE.0000000000001618","article-title":"Quantification of retinal vessel tortuosity in diabetic retinopathy using optical coherence tomography angiography","volume":"38","author":"Lee","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.apsb.2024.03.011_bib31","article-title":"The interplay of environmental luminance and genetics in the retinal dystrophy induced by the dominant RPE65 mutation","volume":"119","author":"Wu","year":"2022","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"93","key":"10.1016\/j.apsb.2024.03.011_bib32","doi-asserted-by":"crossref","DOI":"10.3791\/52204-v","article-title":"Isolation of primary murine brain microvascular endothelial cells","author":"Ruck","year":"2014","journal-title":"J Vis Exp"},{"key":"10.1016\/j.apsb.2024.03.011_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027385","article-title":"A computational tool for quantitative analysis of vascular networks","volume":"6","author":"Zudaire","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2024.03.011_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.707008","article-title":"Association of the monocyte-to-high-density lipoprotein cholesterol ratio with diabetic retinopathy","volume":"8","author":"Tang","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.apsb.2024.03.011_bib35","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2337\/dc20-1815","article-title":"HbA1c change and diabetic retinopathy during GLP-1 receptor agonist cardiovascular outcome trials: a meta-analysis and meta-regression","volume":"44","author":"Bethel","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.apsb.2024.03.011_bib36","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1111\/dom.13339","article-title":"Glucagon-like peptide-1 receptor expression in the human eye","volume":"20","author":"Hebsgaard","year":"2018","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.apsb.2024.03.011_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097302","article-title":"The db\/db mouse: a useful model for the study of diabetic retinal neurodegeneration","volume":"9","author":"Bogdanov","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2024.03.011_bib38","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1007\/s00125-011-2200-y","article-title":"Retinal vascular tortuosity in persons with diabetes and diabetic retinopathy","volume":"54","author":"Sasongko","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.apsb.2024.03.011_bib39","doi-asserted-by":"crossref","first-page":"7556","DOI":"10.1167\/iovs.11-7185","article-title":"Differential expression of claudins in retinas during normal development and the angiogenesis of oxygen-induced retinopathy","volume":"52","author":"Luo","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.apsb.2024.03.011_bib40","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2337\/db19-1121","article-title":"Claudin-5 redistribution induced by inflammation leads to anti-VEGF-resistant diabetic macular edema","volume":"69","author":"Arima","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.apsb.2024.03.011_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2020.05.001","article-title":"GLP-1 receptor signaling in astrocytes regulates fatty acid oxidation, mitochondrial integrity, and function","volume":"31","author":"Timper","year":"2020","journal-title":"Cell Metabol"},{"key":"10.1016\/j.apsb.2024.03.011_bib42","first-page":"17","article-title":"JC-1: alternative excitation wavelengths facilitate mitochondrial membrane potential cytometry","volume":"42","author":"Perelman","year":"2012","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.apsb.2024.03.011_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.09.020","article-title":"TDP-43 triggers mitochondrial DNA release via mPTP to activate cGAS\/STING in ALS","volume":"183","author":"Yu","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2024.03.011_bib44","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41586-022-04559-7","article-title":"Activation of STING by targeting a pocket in the transmembrane domain","volume":"604","author":"Lu","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2024.03.011_bib45","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1096\/fj.201700845R","article-title":"CREB\/CRTC2 controls GLP-1-dependent regulation of glucose homeostasis","volume":"32","author":"Lee","year":"2018","journal-title":"FASEB J"},{"key":"10.1016\/j.apsb.2024.03.011_bib46","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1042\/BST20130283","article-title":"Targeting mitochondria to restore failed adaptation to exercise in diabetes","volume":"42","author":"Geary","year":"2014","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.apsb.2024.03.011_bib47","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s42255-020-00327-x","article-title":"Metabolic messengers: glucagon-like peptide 1","volume":"3","author":"Gribble","year":"2021","journal-title":"Nat Metab"},{"key":"10.1016\/j.apsb.2024.03.011_bib48","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40261-021-01110-w","article-title":"Semaglutide and diabetic retinopathy risk in patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials","volume":"42","author":"Wang","year":"2022","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.apsb.2024.03.011_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.curtheres.2020.100596","article-title":"The effect of dipeptidyl peptidase-4 inhibitors on macrovascular and microvascular complications of diabetes mellitus: a systematic review","volume":"93","author":"Taylor","year":"2020","journal-title":"Curr Ther Res Clin Exp"},{"key":"10.1016\/j.apsb.2024.03.011_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108271","article-title":"GLP-1 receptor agonist NLY01 reduces retinal inflammation and neuron death secondary to ocular hypertension","volume":"33","author":"Sterling","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.apsb.2024.03.011_bib51","article-title":"Exendin-4 promotes retinal ganglion cell survival and function by inhibiting calcium channels in experimental diabetes","volume":"26","author":"Wang","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.apsb.2024.03.011_bib52","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.metabol.2013.04.010","article-title":"GLP-1 promotes angiogenesis in human endothelial cells in a dose-dependent manner, through the Akt, Src and PKC pathways","volume":"62","author":"Aronis","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.apsb.2024.03.011_bib53","doi-asserted-by":"crossref","first-page":"E1209","DOI":"10.1152\/ajpendo.00237.2004","article-title":"Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease","volume":"287","author":"Nystrom","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.apsb.2024.03.011_bib54","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.bbrc.2009.12.075","article-title":"Glucagon-like peptide-1 (GLP-1) inhibits advanced glycation end product (AGE)-induced up-regulation of VCAM-1 mRNA levels in endothelial cells by suppressing AGE receptor (RAGE) expression","volume":"391","author":"Ishibashi","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.apsb.2024.03.011_bib55","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1161\/CIRCULATIONAHA.107.739938","article-title":"Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways","volume":"117","author":"Ban","year":"2008","journal-title":"Circulation"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383524000911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383524000911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T16:09:45Z","timestamp":1716826185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383524000911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2211383524000911"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2024.03.011","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucagon-like peptide-1 receptor agonists rescued diabetic vascular endothelial damage through suppression of aberrant STING signaling","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2024.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}